This inventor holds 6 USPTO granted patents and 9 published patent applications, plus 3 CIPO patents and 5 EPO patents. Top assignee: Novartis Ag. Active years: 2017-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2026
Title: Hanno Richards: Innovator in the Treatment of Ankylosing Spondylitis
Introduction
Hanno Richards, a prominent inventor based in Therwil, Switzerland, has made significant contributions to the medical field with four patented innovations. His work primarily focuses on utilizing Interleukin-17 (IL-17) antagonists in the treatment of inflammatory arthritis conditions, particularly ankylosing spondylitis and psoriatic arthritis.
Latest Patents
Richards' latest patents include groundbreaking methods for treating ankylosing spondylitis using IL-17 antagonists. One notable patent outlines novel regimens that employ a therapeutically effective amount of IL-17 binding molecules, such as IL-17 antibodies or antigen-binding fragments, including secukinumab. Another important patent focuses on utilizing IL-17 antagonists to inhibit the progression of structural damage in patients suffering from psoriatic arthritis. This disclosure encompasses methods, uses, medicaments, pharmaceutical formulations, dosage forms, and kits that utilize IL-17 antibodies and antigen-binding fragments.
Career Highlights
Hanno Richards is currently affiliated with Novartis AG, a leading global healthcare company. His career reflects a commitment to advancing therapeutic options for patients struggling with inflammatory arthritis by leveraging his extensive knowledge of immunology and pharmacology.
Collaborations
Throughout his innovative journey, Richards has had the opportunity to work alongside talented colleagues such as Shephard Mpofu and Karthinathan Thangavelu. Their collaborations have fostered a productive environment, leading to significant advancements in the understanding and treatment of inflammatory arthritides.
Conclusion
Hanno Richards stands out as a dedicated inventor whose work has the potential to enhance the lives of those affected by ankylosing spondylitis and psoriatic arthritis. His patents serve not only as a testament to his expertise but also as critical advancements in the field of medical treatment. The impact of his innovations will likely reverberate through the healthcare industry for years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile